4
Changes in Ownership
Vor Biopharma Inc. Filed Acc 0001231919-25-000342
Director sold 117,050 shares at an average $29.34 ($3,433,992)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2025-10-20 | Sale | −70,366 | $29.63 | $2,084,945 | 1,432,806 | I: show line 1 in the form |
| RA CAPITAL MANAGEMENT, L.P. Director | 2025-10-20 | Sale | −13,817 | $29.63 | $409,398 | 1,287 | I: show line 2 in the form |
| RA CAPITAL MANAGEMENT, L.P. Director | 2025-10-20 | Sale | −6,553 | $30.12 | $197,376 | 1,426,253 | I: show line 3 in the form |
| RA CAPITAL MANAGEMENT, L.P. Director | 2025-10-20 | Sale | −1,287 | $30.12 | $38,764 | 0 | I: show line 4 in the form |
| RA CAPITAL MANAGEMENT, L.P. Director | 2025-10-21 | Sale | −25,027 | $28.11 | $703,509 | 1,401,226 | I: show line 5 in the form |
| Open-market sales · 117,050 sh · avg $29.34 · $3,433,992 | |||||||
Loading xslF345X05/form4-10222025_111059.xml…